Jazz moves into Ireland with Azur buy – RT – News #laureate #pharma

Posted On May 19 2017 by

#azur pharma # Jazz moves into Ireland with Azur buy Thursday 19 January 2012 11.26 US company Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a €1.5 billion specialty drug company headquartered in Dublin. Now named Jazz Pharmaceuticals plc, it has about 430 employees – 20 in Dublin – with offices also in Philadelphia and Palo Alto. One of the founders of Azur was former Elan executive Seamus Mulligan. Azur shareholders will own just over 20% of the new group, with Jazz shareholders owning the remainder of the combined firm. RELATED AUDIO VIDEO Azur Pharma …


Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell College Union #pharma #engineering

Posted On May 19 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …


Jazz moves into Ireland with Azur buy – RT – News #pharmaceutical #industry #trends

Posted On May 2 2017 by

#azur pharma # Jazz moves into Ireland with Azur buy Thursday 19 January 2012 11.26 US company Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a €1.5 billion specialty drug company headquartered in Dublin. Now named Jazz Pharmaceuticals plc, it has about 430 employees – 20 in Dublin – with offices also in Philadelphia and Palo Alto. One of the founders of Azur was former Elan executive Seamus Mulligan. Azur shareholders will own just over 20% of the new group, with Jazz shareholders owning the remainder of the combined firm. RELATED AUDIO VIDEO Azur Pharma …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharma #services

Posted On Apr 23 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Jazz Pharmaceuticals to acquire Azur Pharma #biotechnology

Posted On Apr 23 2017 by

#azur pharma # Jazz Pharmaceuticals to acquire Azur Pharma James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court with attorney Ethan Balogh in New York, U.S. on Jan. 4, 2011. Fleishman and two ex-consultants for expert-networking firm Primary Global Research LLC were released on bail after a hearing before a New York federal judge as part of their prosecution in a nationwide probe of hedge fund insider trading. Photographer: Jeremy Bales/Bloomberg *** Local Caption *** James Fleishman; Ethan Balogh James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court …


Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell College Union #teva #pharma #jobs

Posted On Apr 23 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …


Jazz Pharmaceuticals to acquire Azur Pharma #qrx #pharma

Posted On Apr 14 2017 by

#azur pharma # Jazz Pharmaceuticals to acquire Azur Pharma James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court with attorney Ethan Balogh in New York, U.S. on Jan. 4, 2011. Fleishman and two ex-consultants for expert-networking firm Primary Global Research LLC were released on bail after a hearing before a New York federal judge as part of their prosecution in a nationwide probe of hedge fund insider trading. Photographer: Jeremy Bales/Bloomberg *** Local Caption *** James Fleishman; Ethan Balogh James Fleishman, a former sales manager at Primary Global Research LLC, right, leaves federal court …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharma #chemie

Posted On Apr 14 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell College Union #pharma #consulting #companies

Posted On Apr 6 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #mankind #pharma

Posted On Apr 6 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …